Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Revenue

Virax Biolabs Group had revenue of $4.95K in the half year ending September 30, 2024, a decrease of -14.01%. This brings the company's revenue in the last twelve months to $84.87K, up 7.03% year-over-year. In the fiscal year ending March 31, 2024, Virax Biolabs Group had annual revenue of $156.42K with 1,727.11% growth.

• Revenue (ttm): $84.87K
• Revenue Growth: +7.03%
• P/S Ratio: 36.50
• Revenue / Employee: $4,992
• Employees: 17
• Market Cap: 4.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	156.42K	147.86K	1,727.11%
Mar 31, 2023	8.56K	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	123.82K	23.94K	23.97%
Mar 31, 2020	99.88K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.